Short Wave Pharma

Psilocybin-based Products for Treatment of Mental Health Disorders

Health Tech & Life Sciences

Active

Pre-Funding Ramat HaSharon Founded 2021

Website ↗ LinkedIn

Total raised

—

Stage

Pre-Funding

Founded

2021

Headcount

Ramat HaSharon

Sector

Health Tech & Life Sciences

About

Short Wave Pharma is a biopharmaceutical company developing novel formulations of psilocybin and additional APIs, along with customized delivery methods, for patients living with mental health disorders, neurodegenerative diseases, chronic pain, and any other medical conditions for which psilocybin is known to have a positive effect.

Short Wave Pharma has begun preclinical studies related to its product for anorexia nervosa. The company’s future programs include the development of novel formulations and delivery approaches for chronic pain and neurodegenerative diseases.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery

Technologies

Biologicals

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2CB2BB2G

Name	Short Wave Pharma
Slug	short-wave-pharma
Type	Israeli Startup
Founded	2021
HQ city	Ramat HaSharon
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object], [object Object]
Business models	B2C, B2B, B2G
Target customers	[object Object], [object Object], [object Object]
Status	active
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Website	https://shortwavelifesciences.com

Name	Role	LinkedIn
Rolf Gerritsen
Rivki Stern Youdkevich
Stephen Murphy
Nadya Lisovoder
Stephen Molloy
Keith Coughlan
Ron Lipsky

Short Wave Pharma

About

Sectors & technology

Tags